Total Payments
$69,198
2024 Payments
$7,760
Companies
13
Transactions
100
Medicare Patients
97
Medicare Billing
$12,520
Payment Breakdown by Category
Consulting$38,147 (55.1%)
Research$10,073 (14.6%)
Other$9,540 (13.8%)
Travel$9,175 (13.3%)
Food & Beverage$1,923 (2.8%)
Education$340.95 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $38,147 | 18 | 55.1% |
| Unspecified | $10,073 | 2 | 14.6% |
| Travel and Lodging | $9,175 | 24 | 13.3% |
| Honoraria | $5,200 | 1 | 7.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,340 | 2 | 6.3% |
| Food and Beverage | $1,923 | 48 | 2.8% |
| Education | $340.95 | 5 | 0.5% |
Payments by Type
General
$59,125
98 transactions
Research
$10,073
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IDORSIA PHARMACEUTICALS US INC | $36,521 | 38 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $11,136 | 20 | $0 (2019) |
| LivaNova USA, Inc. | $6,144 | 6 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $5,392 | 17 | $0 (2019) |
| Genentech, Inc. | $4,230 | 2 | $0 (2023) |
| EISAI INC. | $3,636 | 2 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $1,640 | 1 | $0 (2020) |
| Harmony Biosciences LLC | $252.85 | 3 | $0 (2022) |
| ITI, Inc. | $99.99 | 6 | $0 (2023) |
| Sage Therapeutics, Inc. | $50.17 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,760 | 18 | LivaNova USA, Inc. ($6,144) |
| 2023 | $36,744 | 25 | IDORSIA PHARMACEUTICALS US INC ($32,376) |
| 2022 | $2,912 | 17 | IDORSIA PHARMACEUTICALS US INC ($2,572) |
| 2021 | $3,615 | 2 | Eisai Inc. ($3,600) |
| 2020 | $1,640 | 1 | Sunovion Pharmaceuticals Inc. ($1,640) |
| 2019 | $16,456 | 34 | Janssen Pharmaceuticals, Inc ($11,136) |
| 2018 | $22.38 | 1 | Jazz Pharmaceuticals Inc. ($22.38) |
| 2017 | $48.80 | 2 | Jazz Pharmaceuticals Inc. ($48.80) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: CNS | ||||||
| 07/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $603.72 | General |
| Category: Insomnia | ||||||
| 07/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $553.40 | General |
| Category: Insomnia | ||||||
| 07/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $57.35 | General |
| Category: Insomnia | ||||||
| 07/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $57.03 | General |
| Category: Insomnia | ||||||
| 07/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $38.86 | General |
| Category: Insomnia | ||||||
| 07/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $36.00 | General |
| Category: Insomnia | ||||||
| 07/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: Insomnia | ||||||
| 06/03/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $87.50 | General |
| Category: Insomnia | ||||||
| 05/17/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Honoraria | Cash or cash equivalent | $5,200.00 | General |
| Category: Neurology | ||||||
| 05/17/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | Cash or cash equivalent | $62.11 | General |
| Category: Neurology | ||||||
| 05/17/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Neurology | ||||||
| 05/17/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $18.76 | General |
| Category: Neurology | ||||||
| 05/16/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $62.50 | General |
| Category: Insomnia | ||||||
| 05/11/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $315.96 | General |
| Category: Neurology | ||||||
| 04/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: PSYCHIATRY | ||||||
| 04/04/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $527.20 | General |
| Category: Neurology | ||||||
| 03/17/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $46.00 | General |
| Category: Insomnia | ||||||
| 11/28/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Consulting Fee | Cash or cash equivalent | $4,275.00 | General |
| Category: INSOMNIA | ||||||
| 11/28/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | Cash or cash equivalent | $2,405.65 | General |
| Category: INSOMNIA | ||||||
| 11/28/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | Cash or cash equivalent | $300.00 | General |
| Category: INSOMNIA | ||||||
| 11/28/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | Cash or cash equivalent | $50.00 | General |
| Category: INSOMNIA | ||||||
| 11/28/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | Cash or cash equivalent | $31.88 | General |
| Category: INSOMNIA | ||||||
| 11/16/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: INSOMNIA | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CLINCIAL PRACTICE GUIDELINES ON SWITCHING HYPNOTIC MEDICINES (CONSENSUS; PUBLICATION) | IDORSIA PHARMACEUTICALS US INC | $10,073 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 16 | 25 | $4,300 | $1,385 |
| 2022 | 2 | 35 | 63 | $13,536 | $4,966 |
| 2021 | 2 | 27 | 45 | $9,360 | $3,306 |
| 2020 | 1 | 19 | 33 | $8,646 | $2,864 |
Total Patients
97
Total Services
166
Medicare Billing
$12,520
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 25 | $4,300 | $1,385 | 32.2% |
| 90870 | Therapy using electrical currents | Facility | 2022 | 18 | 30 | $7,860 | $2,519 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 33 | $5,676 | $2,447 | 43.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 15 | 27 | $4,644 | $1,862 | 40.1% |
| 90870 | Shock treatment and monitoring | Facility | 2021 | 12 | 18 | $4,716 | $1,443 | 30.6% |
| 90870 | Shock treatment and monitoring | Facility | 2020 | 19 | 33 | $8,646 | $2,864 | 33.1% |
About Dr. William Mccall, MD
Dr. William Mccall, MD is a Psychiatry healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902881485.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Mccall, MD has received a total of $69,198 in payments from pharmaceutical and medical device companies, with $7,760 received in 2024. These payments were reported across 100 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($38,147).
As a Medicare-enrolled provider, Mccall has provided services to 97 Medicare beneficiaries, totaling 166 services with total Medicare billing of $12,520. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Augusta, GA
- Active Since 12/07/2005
- Last Updated 07/18/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1902881485
Products in Payments
- QUVIVIQ (Drug) $34,961
- SPRAVATO (Drug) $11,136
- VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $6,144
- XYREM (Drug) $5,321
- Dayvigo (Drug) $3,600
- LATUDA (Drug) $1,640
- Wakix (Drug) $252.85
- CAPLYTA (Drug) $121.73
- Xyrem (Drug) $71.18
- ARISTADA (Drug) $42.01
- Kcentra (Biological) $33.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Augusta
Joseph Mcevoy, Md, MD
Psychiatry — Payments: $113,605
Psychiatry $113,605
Mary Tyson, M.d, M.D
Psychiatry — Payments: $15,524
Psychiatry $15,524
Dr. Prakash Merai, M.d, M.D
Psychiatry — Payments: $13,057
Psychiatry $13,057
Elizabeth Messulam, Md, MD
Psychiatry — Payments: $11,031
Psychiatry $11,031
Dr. Brian Miller, M.d, M.D
Psychiatry — Payments: $9,544
Psychiatry $9,544
Peter Rosenquist, Md, MD
Psychiatry — Payments: $8,739
Psychiatry $8,739